Source:http://linkedlifedata.com/resource/pubmed/id/19129558
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2009-1-8
|
pubmed:abstractText |
Recently it was shown that myeloid leukemic cells can be induced to differentiate into leukemia-derived dendritic cells (DCleu), regaining the stimulatory capacity of professional DCs while presenting the leukemic antigen repertoire. But so far, the induced antileukemic T-cell responses have varied in specificity and efficacy, or have even mediated opposite effects. In an attempt to further characterize the DC/DCleu induced T-cell response pattern, immunoscope spectratyping, a novel and powerful tool to detect T-cell receptor (TCR) rearrangements was used in combination with functional flow cytometry and non-radioactive fluorolysis assays. Human leucocyte antigen (HLA) matched donor T-cells were repeatedly stimulated, either with leukemic blasts (French-American-British, FAB M4eo) or the corresponding blast-derived DCs. Functional comparison revealed no significant difference in their T-cell stimulatory capacity, while the DC/DCleu fraction favored T-cells with a higher lytic activity, comprising a higher proportion of T-memory CD45R0+ cells. Stimulation with blasts and DC/DCleu induced a similar TCR restriction pattern, while stimulation with DC/DCleu favored the CD4 T-cell subset and seemed to cause a higher grade of restriction. In conclusion, a combined strategy using spectratyping with functional tests might not only provide useful information about the specificity and efficacy of the induced T-cell response, but also pave the way to gain effective T-cell clones for therapeutic use.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1109-6535
|
pubmed:author |
pubmed-author:BorkhardtArndtA,
pubmed-author:BuhmannRaymundR,
pubmed-author:GrabruckerChristineC,
pubmed-author:HubnerBerndB,
pubmed-author:KolbHans-JochemHJ,
pubmed-author:KroellTanjaT,
pubmed-author:LichtnerPeterP,
pubmed-author:LiepertAnjaA,
pubmed-author:ReibkeRolandR,
pubmed-author:ReutherSusanneS,
pubmed-author:SchmetzerHelgaH,
pubmed-author:SchusterFriedhelm RFR,
pubmed-author:YangTingT
|
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
275-86
|
pubmed:dateRevised |
2009-2-13
|
pubmed:meshHeading |
pubmed-meshheading:19129558-Antigens, CD,
pubmed-meshheading:19129558-Blast Crisis,
pubmed-meshheading:19129558-CD4-Positive T-Lymphocytes,
pubmed-meshheading:19129558-Dendritic Cells,
pubmed-meshheading:19129558-Flow Cytometry,
pubmed-meshheading:19129558-Gene Rearrangement,
pubmed-meshheading:19129558-Humans,
pubmed-meshheading:19129558-Immunophenotyping,
pubmed-meshheading:19129558-Leukemia, Myeloid, Acute,
pubmed-meshheading:19129558-Lymphocyte Activation,
pubmed-meshheading:19129558-Receptors, Antigen, T-Cell, alpha-beta,
pubmed-meshheading:19129558-T-Lymphocytes
|
pubmed:articleTitle |
Improved effector function of leukemia-specific T-lymphocyte clones trained with AML-derived dendritic cells.
|
pubmed:affiliation |
Department of Pediatric Oncology, Hematology and Immunology, Heinrich Heine University Medical Center, Dusseldorf, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|